DBV Technologies
DBVT • NASDAQ • Stock Fundamentals
DBV Technologies is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Daniel Tassé, with a market cap of $978.9M.
Market Cap$978.9M
Employees105.0
CEODaniel Tassé
CountryFrance
Healthcare
Biotechnology
Most Recent EarningsApr 30, 2026 · 1 month 15 days agoQ1 2026
View reportNext EarningsJul 29, 2026 · in a monthBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
DBV Technologies FAQ
Common questions about DBV Technologies
DBV Technologies (DBVT) has a market capitalization of $978.9M and trades on NASDAQ.
DBV Technologies has approximately 105 employees.